Skip to content

Author's details

Reviewer's details

Congenital hypothyroidism in resource-limited settings, including Nigeria

Key Messages

  • CH is a recognised cause of physical growth impairment and intellectual disability
  • Congenital hypothyroidism is treatable; early diagnosis protects brain development and growth.
  • An apparently well newborn may be affected—do not wait for classical signs.
  • Test serum TSH and free T4; normal TSH does not exclude central hypothyroidism.
  • Start appropriate levothyroxine promptly; do not delay treatment for imaging.
  • Universal newborn screening must be linked to confirmatory testing, treatment and long-term follow-up.
Background

Congenital hypothyroidism (CH) is thyroid hormone deficiency present at birth. It may result from an abnormal thyroid gland or inadequate stimulation of the gland by the hypothalamus or pituitary. Thyroid hormones are essential for brain development, linear growth and metabolism, particularly during fetal life and early childhood.

How thyroid hormones work. The thyroid gland makes two hormones: thyroxine (T4) and a smaller amount of triiodothyronine (T3). T4 is largely a storage form, while T3 is the more active form and is made mostly by converting T4 in the body’s tissues. In the blood, most T4 is attached (bound) to carrier proteins and cannot act while bound. Only a very small fraction, called free T4 (fT4), is unbound and able to enter cells, so fT4 reflects the hormone the body can use. It is a more reliable measure than total T4, which changes with the level of carrier proteins. The amount of hormone produced is controlled by a feedback loop: the hypothalamus and pituitary gland release thyroid-stimulating hormone (TSH), which signals the thyroid to make more hormone. When fT4 is low, the pituitary normally raises TSH; when fT4 is adequate, TSH falls. This is why primary CH shows low fT4 with high TSH, and why central CH can show low fT4 with a low or normal TSH.

CH is an important preventable cause of intellectual disability. Early diagnosis and adequate treatment are therefore priorities in newborn care. Incidence estimates from other populations should not be used as estimates for Nigeria or the wider sub-Saharan African region. A UNTH outpatient study reported a 0.9% prevalence of hypothyroidism among outpatients, predominantly adults; it did not measure congenital hypothyroidism in newborns.

This review is intended for doctors caring for newborns and children in sub-Saharan Africa, with Nigeria as the main example. Where routine newborn screening is unavailable, the practical priorities are to recognise possible CH, obtain thyroid function tests promptly, initiate appropriate treatment and arrange follow-up. Clinical assessment alone cannot reliably exclude CH.

Discussion

Causes of congenital hypothyroidism

The causes can be grouped into disorders of the thyroid gland, disorders of its regulatory pathways, and maternal or environmental factors. Identifying the cause helps determine whether treatment is likely to be temporary or lifelong.

The major causes include:

  1. Thyroid dysgenesis (abnormal development of the thyroid gland)

Thyroid dysgenesis means abnormal development of the thyroid gland. The gland may be absent (agenesis), small (hypoplasia) or situated outside its usual position (ectopia). It is a major cause of permanent CH. Associated developmental genes include TTF-1, TTF-2 and PAX8; detailed genetic investigation is not the priority when assessing a suspected case.

  1. Thyroid dyshormonogenesis (defective thyroid hormone production)

Thyroid dyshormonogenesis means impaired thyroid hormone synthesis despite the presence of thyroid tissue. Inherited defects may involve thyroid peroxidase, thyroglobulin, pendrin, the sodium–iodide symporter or thyroid oxidase. These disorders are usually autosomal recessive.

  1. Maternal exposure to certain medications and substances during pregnancy

Maternal exposure to antithyroid medicines, radioactive iodine or excessive or inadequate iodine can affect fetal or neonatal thyroid function. Ask specifically about thyroid disease, medicines and iodine exposure during pregnancy.

  1. Disorders of the thyroid hormone regulatory pathways (Hypothalamic or pituitary abnormalities)

Abnormalities of the hypothalamus or pituitary may prevent adequate stimulation of the thyroid gland. This causes central CH, which requires a different interpretation of thyroid function tests from primary CH.

  1. Other causes

Other causes include iodine deficiency and maternal TSH receptor-blocking antibodies. These antibodies can cross the placenta and temporarily inhibit the baby’s thyroid function.

Classification of congenital hypothyroidism

Classify CH in two ways: by the site of the defect (primary or central) and by its duration (transient or permanent). These categories answer different questions and should not be treated as alternatives.

a. Primary and Secondary hypothyroidism

  • Primary hypothyroidism

Primary CH originates in the thyroid gland. In overt disease, free thyroxine (fT4) is low and thyroid-stimulating hormone (TSH) is elevated. The raised TSH reflects the pituitary response to inadequate thyroid hormone production.

  • Central hypothyroidism

Central CH originates in the hypothalamus or pituitary. The typical pattern is low fT4 with low or inappropriately normal TSH: the TSH is not raised as expected for the low fT4. A normal TSH therefore does not exclude CH. Screening with only TSH can miss central CH that may occur with other pituitary hormone deficiencies. 

b. Transient and permanent congenital hypothyroidism

Transient CH: thyroid dysfunction resolves over time. Causes include maternal TSH receptor-blocking antibodies, antithyroid medicines and iodine imbalance. Resolution must be demonstrated by reassessment; it should not be assumed because a child appears well.

Permanent CH: a persistent structural or functional defect affects the thyroid gland or its regulatory pathways. Long-term, often lifelong, levothyroxine replacement is required.

Clinical features of congenital hypothyroidism

Most babies with CH have few or no obvious signs at birth. Placental transfer of maternal thyroxine provides some temporary support, so symptoms may appear only after birth. Do not wait for a characteristic appearance before investigating. Early features include:

  • Prolonged neonatal jaundice due to delayed maturation of bilirubin conjugation
  • Poor feeding or difficulty feeding
  • Excessive sleepiness and lethargy
  • Constipation
  • Poor muscle tone (hypotonia)
  • Slightly increased head circumference
  • Larger posterior fontanelle (>0.5 cm)

With prolonged untreated thyroid hormone deficiency, the following features may become more apparent. Their presence should prompt investigation, but their absence does not exclude CH:

  • Coarse facial features
  • A large tongue (macroglossia), which may cause breathing and feeding difficulties
  • A large or persistently open anterior fontanelle
  • A hoarse cry
  • Coarse, dry and mottled skin
  • Swelling around the eyes, hands and genital region (myxoedema)
  • Umbilical hernia
  • Low body temperature (hypothermia)
  • Prominent forehead hairline or excessive forehead hair
  • Anaemia, which may not respond readily to treatment
  • Poor growth and delayed development

Clinical scoring systems (Appendix) can help organise an examination, but they cannot replace newborn screening or thyroid function testing. A child with suggestive symptoms requires testing even if the clinical score is low or a previous newborn screen was normal. Waiting for several classical signs risk delayed diagnosis.

Diagnosis of congenital hypothyroidism in resource-limited settings

Where newborn screening is unavailable, investigate CH when an infant has prolonged jaundice, poor feeding, constipation, lethargy, hypotonia, hypothermia or delayed growth and development. Obtain a maternal thyroid history and examine the infant carefully. In a child presenting after the neonatal period, do not dismiss CH because the opportunity for early screening has passed.

Prioritise tests that confirm thyroid dysfunction. Investigations to identify the underlying cause are useful but should not hold up treatment of confirmed disease.

1. Essential: serum TSH and fT4. Request both tests when CH is suspected. Use the laboratory’s age-specific reference ranges rather than adult ranges. Suggestive symptoms warrant testing even after a normal newborn screen.

  • Primary CH: low fT4 with elevated TSH is the typical pattern in overt disease. T3 is not a reliable test for excluding CH.
  • Possible central CH: low fT4 with low or inappropriately normal TSH requires specialist assessment. Do not interpret a normal TSH in isolation as normal thyroid function.

2. Thyroid imaging: identify the cause. Ultrasound assesses the presence, size and position of the gland. Radionuclide scintigraphy, where available, provides complementary information about functioning thyroid tissue and ectopia. Do not delay treatment while waiting for an isotope scan.

3. Maternal history and targeted antibody assessment. Ask about maternal thyroid disease and antithyroid medicine use. Where available and clinically indicated, maternal and infant TSH receptor-blocking antibody testing may help identify antibody-mediated transient CH. It does not replace the infant’s TSH and fT4 tests.

4. Radiological assessment: supportive, not confirmatory. A knee radiograph may show delayed bone maturation, including absent or delayed appearance of the distal femoral epiphysis. This can support the assessment but cannot substitute for thyroid function tests.

 

Differential diagnosis

Some syndromes and metabolic disorders share features with CH. Consider the overall clinical picture and use appropriate investigations; one shared sign, such as macroglossia or hypotonia, is not sufficient to establish the diagnosis.

Some important differential diagnoses include:

  1. Down syndrome (trisomy 21): hypotonia, a protruding tongue and developmental delay may resemble CH. The conditions can coexist, so a diagnosis of Down syndrome does not exclude thyroid dysfunction.
  2. Beckwith–Wiedemann syndrome: macroglossia, umbilical hernia or other abdominal wall defects may resemble CH, but excessive growth is an important distinguishing feature.
  3. Inborn errors of metabolism: some mucopolysaccharidoses and glycogen storage diseases cause coarse facial features, hepatomegaly, developmental difficulties and umbilical hernia.

Use clinical assessment to guide further investigation, while obtaining thyroid function tests when CH remains a possibility.

Treatment and management

Levothyroxine is the standard treatment for CH. Start appropriate replacement promptly once the diagnosis is established; the aim in newborns is to begin within the first two weeks of life. A child diagnosed later still needs prompt treatment. Do not wait for classical signs or an imaging appointment.

Initial dose in neonatal primary CH: oral levothyroxine 10–15 micrograms/kg/day is recommended. The exact prescription should account for severity and follow local paediatric guidance; this neonatal recommendation should not be applied unchanged to older children or central CH.

Treatment must be prescribed for the individual child and guided by biochemical monitoring. Practical points include:

  • Give levothyroxine orally every day, consistently and preferably at the same time.
  • When a tablet is used for an infant, crush it and mix it with a small quantity of water or breast milk. Ensure that the full prescribed dose is administered.
  • Do not mix the dose with soy-based feeds or give it together with iron or calcium supplements, as these can impair absorption.

Monitor TSH and fT4 regularly and adjust the dose to avoid both under-replacement and over-replacement. For primary CH in early childhood, treatment targets include a normal TSH and fT4 in the upper half of the age-specific reference range. Arrange ongoing review of growth, development and hearing.

Permanent CH usually requires lifelong treatment. Possible transient CH requires specialist-led reassessment before treatment is withdrawn. Improvement in symptoms alone is not evidence that replacement is no longer needed.

Safety in suspected central CH: obtain urgent paediatric endocrine advice about associated pituitary hormone deficiencies, including adrenal insufficiency. If cortisol deficiency is present, glucocorticoid replacement must precede levothyroxine to avoid precipitating adrenal crisis. TSH alone is not a suitable guide to replacement in central hypothyroidism.

Prognosis

Outcome depends on the cause and severity of CH, the timing of treatment, and sustained adequate hormone replacement. Early treatment gives the best opportunity for normal growth and favourable neurodevelopment.

Delayed diagnosis may leave lasting cognitive and developmental difficulties even after treatment begins. However, late presentation is not a reason to withhold treatment. Continue thyroid hormone replacement, assess growth and development, and arrange appropriate developmental support.

Clinical experience

In my clinical practice, I encountered an infant with transient CH who was born to a mother with hyperthyroidism.

The maternal history raised suspicion, and thyroid function tests supported the diagnosis.

The infant had few obvious clinical signs; hypothermia was the main finding. The paediatric endocrinology team prescribed levothyroxine and took over ongoing management.

The key lesson was that CH may be present without the classical physical features. Maternal history can identify a baby who needs testing, but thyroid function tests and follow-up are necessary to establish the diagnosis and determine whether the disorder is transient.

Conclusion

CH is a treatable cause of impaired growth and neurodevelopment. The most important clinical message is that an apparently well newborn can still be affected. Early recognition, biochemical confirmation and adequate treatment can prevent much of the harm.

For doctors practising where routine screening is unavailable, clinical vigilance is a necessary interim approach, not a substitute for universal newborn screening. At each relevant consultation, consider CH in infants with suggestive symptoms and organise testing rather than waiting for a fully developed clinical picture.

Nigeria and other settings with limited screening coverage need pathways that link newborn screening to confirmatory testing, prompt treatment, referral and long-term follow-up. A screening result is useful only if the family can access the next steps in care. The priorities are reliable testing, continuity of treatment and a clear follow-up plan.

Reflection

It is concerning that a newborn with a treatable disorder may remain undiagnosed until thyroid hormone deficiency has affected development. This makes delayed recognition of CH an important issue for clinicians working where screening is not routinely accessible.

I chose this topic to advocate for early diagnosis and timely treatment for every newborn. My focus is the introduction and strengthening of universal CH screening in Nigeria, linked to accessible testing, treatment and follow-up.

Appendix
CLINICAL FEATURES SCORE
Typical facies 3
Dry skin 1.5
Open posterior fontanel >0.5cm 1.5
Feeding Problem 1
Constipation 1
Poor activity 1
Poor muscle tone 1
Large tongue 1
Skin mottling 1
Umbilical Hernia >0.5cm 1
TOTAL 13

Source: Neonatal Hypothyroid Index, as presented in reference 1 (Vinod et al., 2024).

Interpretation: The original index states that scores >3 should prompt screening. A score of 3 or less does not exclude CH. Investigate a clinically suspicious infant regardless of the score, using serum TSH and fT4. 

Interesting patient case

An infant born to a mother with hyperthyroidism presented with hypothermia but few other clinical signs. Thyroid function tests supported congenital hypothyroidism. The paediatric endocrinology team commenced levothyroxine and arranged ongoing care.

Chart

Related Topics

No data was found
Further readings
  1. Vinod BS, Sumathi S, karthikeyan K, Kuzhandhai Velu V and Sowmiya T. Congenital Hypothyroidism – A Broad Review. African Journal of Biomedical Research Research 2024; 27(35): 1704-10. Available at https://doi.org/10.53555/AJBR.v27i35.1789.
  2. Anochie IF, Elusiyan JBE, Yarhere I. Other endocrine and metabolic disorders. In: Azubuike JC, Nkangineme KEO, editors. Paediatrics and Child Health in a Tropical Region. 3rd ed. Lagos: Educational Printing and Publishing; 2016. p. 952–967.
  3. Okafor EN, Ugonabo MC, Chukwukelu EE, Okonkwo IN, Ezigbo E, Odurukwe O. Prevalence and Pattern of Thyroid Disorders among Patients Attending University of Nigeria Teaching Hospital Enugu, Southeastern Nigeria. Niger Med J. 2019; 60(2): 62-7. doi: 10.4103/nmj.NMJ_34_19.
  4. Echendu ST, Ebenebe JC, Uchefuna CN, Umeadi EN, Okeke KN, Anyabolu EN et al. Delayed Diagnosis of Congenital Hypothyroidism: Challenges of Management in a Low-income Setting – A case Report. Trop J Med Res 2025; 24(1): doi.10.5281/zenodo.14658337.
  5. Kayode-Adedeji B.O and Alikah S.O. Congenital Hypothyroidism in a Five Year Old Nigerian Girl. A Case Report. Internatiomal Journal of Basic Applied and Innovative Research 2015; 4(1): 15-19.
  6. Sheanon NM, Muglia LJ. The endocrine system. In: Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, editors. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2020. p. 4203–4217.

Advertise on Medicobridge

Author's details

Reviewer's details

Congenital hypothyroidism in resource-limited settings, including Nigeria

Congenital hypothyroidism (CH) is thyroid hormone deficiency present at birth. It may result from an abnormal thyroid gland or inadequate stimulation of the gland by the hypothalamus or pituitary. Thyroid hormones are essential for brain development, linear growth and metabolism, particularly during fetal life and early childhood.

How thyroid hormones work. The thyroid gland makes two hormones: thyroxine (T4) and a smaller amount of triiodothyronine (T3). T4 is largely a storage form, while T3 is the more active form and is made mostly by converting T4 in the body’s tissues. In the blood, most T4 is attached (bound) to carrier proteins and cannot act while bound. Only a very small fraction, called free T4 (fT4), is unbound and able to enter cells, so fT4 reflects the hormone the body can use. It is a more reliable measure than total T4, which changes with the level of carrier proteins. The amount of hormone produced is controlled by a feedback loop: the hypothalamus and pituitary gland release thyroid-stimulating hormone (TSH), which signals the thyroid to make more hormone. When fT4 is low, the pituitary normally raises TSH; when fT4 is adequate, TSH falls. This is why primary CH shows low fT4 with high TSH, and why central CH can show low fT4 with a low or normal TSH.

CH is an important preventable cause of intellectual disability. Early diagnosis and adequate treatment are therefore priorities in newborn care. Incidence estimates from other populations should not be used as estimates for Nigeria or the wider sub-Saharan African region. A UNTH outpatient study reported a 0.9% prevalence of hypothyroidism among outpatients, predominantly adults; it did not measure congenital hypothyroidism in newborns.

This review is intended for doctors caring for newborns and children in sub-Saharan Africa, with Nigeria as the main example. Where routine newborn screening is unavailable, the practical priorities are to recognise possible CH, obtain thyroid function tests promptly, initiate appropriate treatment and arrange follow-up. Clinical assessment alone cannot reliably exclude CH.

  1. Vinod BS, Sumathi S, karthikeyan K, Kuzhandhai Velu V and Sowmiya T. Congenital Hypothyroidism – A Broad Review. African Journal of Biomedical Research Research 2024; 27(35): 1704-10. Available at https://doi.org/10.53555/AJBR.v27i35.1789.
  2. Anochie IF, Elusiyan JBE, Yarhere I. Other endocrine and metabolic disorders. In: Azubuike JC, Nkangineme KEO, editors. Paediatrics and Child Health in a Tropical Region. 3rd ed. Lagos: Educational Printing and Publishing; 2016. p. 952–967.
  3. Okafor EN, Ugonabo MC, Chukwukelu EE, Okonkwo IN, Ezigbo E, Odurukwe O. Prevalence and Pattern of Thyroid Disorders among Patients Attending University of Nigeria Teaching Hospital Enugu, Southeastern Nigeria. Niger Med J. 2019; 60(2): 62-7. doi: 10.4103/nmj.NMJ_34_19.
  4. Echendu ST, Ebenebe JC, Uchefuna CN, Umeadi EN, Okeke KN, Anyabolu EN et al. Delayed Diagnosis of Congenital Hypothyroidism: Challenges of Management in a Low-income Setting – A case Report. Trop J Med Res 2025; 24(1): doi.10.5281/zenodo.14658337.
  5. Kayode-Adedeji B.O and Alikah S.O. Congenital Hypothyroidism in a Five Year Old Nigerian Girl. A Case Report. Internatiomal Journal of Basic Applied and Innovative Research 2015; 4(1): 15-19.
  6. Sheanon NM, Muglia LJ. The endocrine system. In: Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, editors. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2020. p. 4203–4217.

Content

Author's details

Reviewer's details

Congenital hypothyroidism in resource-limited settings, including Nigeria

Congenital hypothyroidism (CH) is thyroid hormone deficiency present at birth. It may result from an abnormal thyroid gland or inadequate stimulation of the gland by the hypothalamus or pituitary. Thyroid hormones are essential for brain development, linear growth and metabolism, particularly during fetal life and early childhood.

How thyroid hormones work. The thyroid gland makes two hormones: thyroxine (T4) and a smaller amount of triiodothyronine (T3). T4 is largely a storage form, while T3 is the more active form and is made mostly by converting T4 in the body’s tissues. In the blood, most T4 is attached (bound) to carrier proteins and cannot act while bound. Only a very small fraction, called free T4 (fT4), is unbound and able to enter cells, so fT4 reflects the hormone the body can use. It is a more reliable measure than total T4, which changes with the level of carrier proteins. The amount of hormone produced is controlled by a feedback loop: the hypothalamus and pituitary gland release thyroid-stimulating hormone (TSH), which signals the thyroid to make more hormone. When fT4 is low, the pituitary normally raises TSH; when fT4 is adequate, TSH falls. This is why primary CH shows low fT4 with high TSH, and why central CH can show low fT4 with a low or normal TSH.

CH is an important preventable cause of intellectual disability. Early diagnosis and adequate treatment are therefore priorities in newborn care. Incidence estimates from other populations should not be used as estimates for Nigeria or the wider sub-Saharan African region. A UNTH outpatient study reported a 0.9% prevalence of hypothyroidism among outpatients, predominantly adults; it did not measure congenital hypothyroidism in newborns.

This review is intended for doctors caring for newborns and children in sub-Saharan Africa, with Nigeria as the main example. Where routine newborn screening is unavailable, the practical priorities are to recognise possible CH, obtain thyroid function tests promptly, initiate appropriate treatment and arrange follow-up. Clinical assessment alone cannot reliably exclude CH.

  1. Vinod BS, Sumathi S, karthikeyan K, Kuzhandhai Velu V and Sowmiya T. Congenital Hypothyroidism – A Broad Review. African Journal of Biomedical Research Research 2024; 27(35): 1704-10. Available at https://doi.org/10.53555/AJBR.v27i35.1789.
  2. Anochie IF, Elusiyan JBE, Yarhere I. Other endocrine and metabolic disorders. In: Azubuike JC, Nkangineme KEO, editors. Paediatrics and Child Health in a Tropical Region. 3rd ed. Lagos: Educational Printing and Publishing; 2016. p. 952–967.
  3. Okafor EN, Ugonabo MC, Chukwukelu EE, Okonkwo IN, Ezigbo E, Odurukwe O. Prevalence and Pattern of Thyroid Disorders among Patients Attending University of Nigeria Teaching Hospital Enugu, Southeastern Nigeria. Niger Med J. 2019; 60(2): 62-7. doi: 10.4103/nmj.NMJ_34_19.
  4. Echendu ST, Ebenebe JC, Uchefuna CN, Umeadi EN, Okeke KN, Anyabolu EN et al. Delayed Diagnosis of Congenital Hypothyroidism: Challenges of Management in a Low-income Setting – A case Report. Trop J Med Res 2025; 24(1): doi.10.5281/zenodo.14658337.
  5. Kayode-Adedeji B.O and Alikah S.O. Congenital Hypothyroidism in a Five Year Old Nigerian Girl. A Case Report. Internatiomal Journal of Basic Applied and Innovative Research 2015; 4(1): 15-19.
  6. Sheanon NM, Muglia LJ. The endocrine system. In: Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, editors. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2020. p. 4203–4217.
Advertisement

Are you a Medical Doctor?